Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms

Background & objectives: Staphylococcus epidermidis is the most common pathogen associated with infections of surgical implants and other prosthetic devices owing to its adhesion and biofilm-forming ability on biomaterials surfaces. The objective of this study was to compare susceptibilities of biofilm-grown cells to single antibiotic and in combination with others to identify those that were effective against S. epidermidis biofilms. Methods: Biofilms were grown in the MBEC™ assay system. The use of this methodology allowed a rapid testing of an array of antibiotics alone (eight) and in combination (25 double combinations). The antibacterial effect of all treatments tested was determined by colony forming units (cfu) enumeration method. Results: The MBEC™ assay system produced multiple and reproducible biofilms of S. epidermidis. Although none of the antibiotics tested have demonstrated an antimicrobial effect (log reduction >3) against all S. epidermidis isolates biofilms, but combinations containing rifampicin showed in general a broader spectrum namely rifampicin-gentamicin and rifampicin-clindamycin. Levofloxacin in combination with rifampicin showed a killing effect against three isolates but failed to attain a bactericidal action against the other two. Interpretation & conclusions: Our findings showed that rifampicin should be a part of any antibiotic therapy directed against S. epidermidis biofilms. However, the efficient antibiotics combination might be dependent on S. epidermidis isolate being tested.

[1]  P. Gilbert,et al.  Biofilm Susceptibility to Antimicrobials , 1997, Advances in dental research.

[2]  R. Moellering Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  C. Beauchamp Effects of Vancomycin, Daptomycin, Fosfomycin, Tigecycline, and Ceftriaxone on Staphylococcus epidermidis Biofilms , 2010 .

[4]  F. Tubau,et al.  Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain , 2010, BMC Microbiology.

[5]  M. Vaara,et al.  Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. , 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[6]  M. Sande,et al.  Reconsideration of rifampin: a unique drug for a unique infection. , 1998, JAMA.

[7]  G. Verschraegen,et al.  Role of coagulase-negative staphylococci in human disease. , 2009, Veterinary microbiology.

[8]  G. Pier,et al.  Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. , 2005, The Journal of antimicrobial chemotherapy.

[9]  M. Upton,et al.  Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis , 2009, Journal of Clinical Pathology.

[10]  J. Leiva,et al.  Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. , 2001, The Journal of antimicrobial chemotherapy.

[11]  H. Rohde,et al.  Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis , 2002, Medical Microbiology and Immunology.

[12]  H. Ceri,et al.  The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms , 1999, Journal of Clinical Microbiology.

[13]  M. Otto Staphylococcus epidermidis — the 'accidental' pathogen , 2009, Nature Reviews Microbiology.

[14]  Å. Nilsdotter-Augustinsson,et al.  Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  E. Fischer,et al.  Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. , 2003, The Journal of infectious diseases.

[16]  H. Ceri,et al.  Characterization of biofilm growth and biocide susceptibility testing of Mycobacterium phlei using the MBEC assay system. , 2001, FEMS microbiology letters.

[17]  B. Trautner,et al.  Combination of Tigecycline and N-Acetylcysteine Reduces Biofilm-Embedded Bacteria on Vascular Catheters , 2007, Antimicrobial Agents and Chemotherapy.

[18]  G. O’Toole,et al.  Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.

[19]  S. Aaron,et al.  Multiple Combination Bactericidal Testing of Staphylococcal Biofilms from Implant-Associated Infections , 2006, Antimicrobial Agents and Chemotherapy.

[20]  K. Dai,et al.  Effect of berberine on Staphylococcus epidermidis biofilm formation. , 2009, International journal of antimicrobial agents.

[21]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[22]  M. Vaara,et al.  Increased resistance amongStaphylococcus epidermidis isolates in a large teaching hospital over a 12-year period , 1996, European Journal of Clinical Microbiology and Infectious Diseases.

[23]  H. Ceri,et al.  Copper and Quaternary Ammonium Cations Exert Synergistic Bactericidal and Antibiofilm Activity against Pseudomonas aeruginosa , 2008, Antimicrobial Agents and Chemotherapy.

[24]  L. Bastide,et al.  In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. , 2006, The Journal of antimicrobial chemotherapy.